Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.
about
Mortality hazard and survival after tuberculosis treatmentLongevity loss among cured tuberculosis patients and the potential value of preventionTuberculosis treatment managed by providers outside the Public Health Department: lessons for the Affordable Care ActTreatment of Active Tuberculosis in Chicago, 2008-2011: The Role of Public Health DepartmentsElephant-to-human transmission of tuberculosis, 2009Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study.Assessing the validity of tuberculosis surveillance data in California.U.S. medical resident familiarity with national tuberculosis guidelinesField assessment of a model tuberculosis outbreak response plan for low-incidence areas.Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals.Antibodies against immunodominant antigens of Mycobacterium tuberculosis in subjects with suspected tuberculosis in the United States compared by HIV status.Economics of United States tuberculosis airline contact investigation policies: a return on investment analysisCost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.Opportunities for tuberculosis diagnosis and prevention among persons living with HIV: a cross-sectional study of policies and practices at four large Ryan White Program-Funded HIV clinicsUtilization of the QuantiFERON-TB Gold test in a two-step process with the tuberculin skin test to evaluate health care workers for latent tuberculosis.Estimating the burden of tuberculosis among foreign-born persons acquired prior to entering the U.S., 2005-2009.Development and application of multiprobe real-time PCR method targeting the hsp65 gene for differentiation of Mycobacterium species from isolates and sputum specimens.High utility of contact investigation for latent and active tuberculosis case detection among the contacts: a retrospective cohort study in Tbilisi, Georgia, 2010-2011.Adherence by Dutch public health nurses to the national guidelines for tuberculosis contact investigation.Tuberculosis of spineSubstance abuse treatment as HIV prevention: more questions than answersPoor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of GeorgiaImproved detection of latent Mycobacterium tuberculosis infection in HIV-1 seropositive individuals using cultured cellular assays.The road to tuberculosis (Mycobacterium tuberculosis) elimination in Arkansas; a re-examination of risk groupsCharacteristics of tuberculosis cases that started outbreaks in the United States, 2002-2011.Tuberculosis outbreak investigations in the United States, 2002-2008.Tuberculosis: evidence review for newly arriving immigrants and refugees.Close contact investigation of TB in high-burden, low- and middle-income countries.Anti-phospholipid antibody levels as biomarker for monitoring tuberculosis treatment response.Factors associated with recently transmitted Mycobacterium tuberculosis strain MS0006 in Hinds County, MississippiPassenger contact investigation associated with a transport driver with pulmonary tuberculosisSeparation of Mycobacterium abscessus into subspecies or genotype level by direct application of peptide nucleic acid multi-probe- real-time PCR method into sputa samples.Enhanced Tuberculosis Infection Treatment Outcomes after Implementation of QuantiFERON®-Gold Testing.Innovative quality-assurance strategies for tuberculosis surveillance in the United StatesLatent Tuberculosis in Pregnancy: A Systematic Review.Multidrug-resistant tuberculosis in military recruits.HIV status determination among tuberculosis patients from California during 2008.Epidemiology and challenges to the elimination of global tuberculosis.Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis
P2860
Q28391275-28318ACC-813C-4D8E-AEBA-A94F4109744CQ28395929-15ED31C2-ECB0-4B9D-AB9C-3FA7E0FB53ECQ28544033-6F45BCB3-4CEF-4F0E-8510-A95A58EF7E6DQ28554665-17CA0175-A9E1-473C-B476-B14F48EF364AQ28740838-4BA19E29-152A-45A5-8760-81F50F650A30Q30840526-5EC040C4-6767-4A63-98BB-21AA7BB03ACAQ33255129-456B3AA8-877D-45B5-86B1-CAF1FF4C0F9AQ33293231-DA4D0355-5D73-4581-A4D6-0D3CCF1D9E91Q33304045-B3C8A3C6-A60D-45F2-BA63-CF38D9129C9DQ33408006-0EA14D8D-BD80-4103-842A-AE64C1F1FD62Q33725116-714B254C-3234-4C3B-924C-08A0232D091FQ33746084-2F73E9CF-6449-46EB-9B80-DD3CD01A0F81Q33746114-B0CEC995-FB2C-4732-A02E-AD016439F961Q33855555-2BD7B4E2-51C3-4630-A7E0-8CA21C438CB6Q34046364-2B42C642-8845-4B58-9C11-2DCA4B70889DQ34090979-F1907EC9-2F66-4967-839E-C977EE2AE761Q34120430-78F0DAA9-CA92-4F28-B294-B282C6684084Q34472922-9C8C2AD4-1B16-4EDB-AC63-82FC55E402E0Q34482655-71F5F665-FFE8-48F8-800E-E511C0AE062AQ34787836-60A2912C-B37D-4C4B-AC5E-F22140461812Q34991140-31F89862-3C9F-44F4-89F7-ACEDABB4752AQ35029529-744753C5-A1C7-4E42-8451-519E64134F68Q35057319-9E5A0C46-B33F-445F-96C3-9E815AA3E5D1Q35117900-3F6E01D5-ED45-4618-89CF-431E1C38B0B7Q35130355-5137032C-6F67-4F97-BF6A-1D23F6C22D9FQ35193559-2F317FAD-A3F0-4E9B-9E1E-C058CC82C7EBQ35201314-CF43D7A6-379A-4039-95AA-7DC77724CDC0Q35443130-2E58C100-F1D4-45D3-96BD-656352D33947Q35534267-075CEDE4-7C0C-497F-B5F2-98428EC9EE4EQ35563755-FB9DE80B-046D-4D2B-A7AF-7581919D22FCQ35712717-899C3CFC-8EFD-49B4-96BF-6F2679C1A61AQ35741746-8C67FC10-ED08-424C-87F7-635271787B52Q35775769-184FF4E3-3597-450B-91F0-A2AB1787BCDEQ35996547-10693A8E-D387-483D-B22D-8DECD1AA435DQ36009482-45C50FF9-851B-4FCB-AE04-CCFBE4981C1FQ36029421-AF14E407-5C73-4D98-B06D-7BB9A7BA7361Q36036710-530F180F-5136-43C3-A59E-A3DCD42744CAQ36073115-C08417B5-21DB-4BD2-BE4E-68D5EFCA5A74Q36112266-114AE787-95C2-48D3-9FA2-F56F1EAB04ECQ36131061-9FBB2148-2D33-4912-A351-1DFD3795BF12
P2860
Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Controlling tuberculosis in th ...... s Diseases Society of America.
@ast
Controlling tuberculosis in th ...... s Diseases Society of America.
@en
type
label
Controlling tuberculosis in th ...... s Diseases Society of America.
@ast
Controlling tuberculosis in th ...... s Diseases Society of America.
@en
prefLabel
Controlling tuberculosis in th ...... s Diseases Society of America.
@ast
Controlling tuberculosis in th ...... s Diseases Society of America.
@en
P2093
P50
P1476
Controlling tuberculosis in th ...... us Diseases Society of America
@en
P2093
Charles M Nolan
Henry M Blumberg
Zachary Taylor
P50
P577
2005-11-01T00:00:00Z